Streptozocinium [Latin]
Brand names,
Streptozocinium [Latin]
Analogs
Streptozocinium [Latin]
Brand Names Mixture
Streptozocinium [Latin]
Chemical_Formula
C8H15N3O7
Streptozocinium [Latin]
RX_link
http://www.rxlist.com/cgi/generic/zanosar.htm
Streptozocinium [Latin]
fda sheet
Streptozocinium [Latin]
msds (material safety sheet)
Streptozocinium [Latin]
Synthesis Reference
No information avaliable
Streptozocinium [Latin]
Molecular Weight
265.221 g/mol
Streptozocinium [Latin]
Melting Point
115 oC
Streptozocinium [Latin]
H2O Solubility
5070 mg/L
Streptozocinium [Latin]
State
Solid
Streptozocinium [Latin]
LogP
-2.958
Streptozocinium [Latin]
Dosage Forms
Powder for solution
Streptozocinium [Latin]
Indication
For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).
Streptozocinium [Latin]
Pharmacology
Streptozocin is an antitumour antibiotic consisting of a nitrosourea moiety interposed between a methyl group and a glucosamine. Streptozocin is indicated in the treatment of metastatic islet cell carcinoma of the pancreas. Streptozocin inhibits DNA synthesis in bacterial and mammalian cells. In bacterial cells, a specific interaction with cytosine moieties leads to degradation of DNA. The biochemical mechanism leading to mammalian cell death has not been definitely established; streptozocin inhibits cell proliferation at a considerably lower level than that needed to inhibit precursor incorporation into DNA or to inhibit several of the enzymes involved in DNA synthesis. Although streptozocin inhibits the progression of cells into mitosis, no specific phase of the cell cycle is particularly sensitive to its lethal effects.
Streptozocinium [Latin]
Absorption
Poor oral absorption (17-25%)
Streptozocinium [Latin]
side effects and Toxicity
Symptoms of overdose include nausea and vomiting, anorexia, myelosuppression; and nephrotoxicity.
Streptozocinium [Latin]
Patient Information
No information avaliable
Streptozocinium [Latin]
Organisms Affected
Humans and other mammals